GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Tianyu Pharmaceutical Co Ltd (SZSE:300702) » Definitions » Research & Development

Zhejiang Tianyu Pharmaceutical Co (SZSE:300702) Research & Development : ¥242 Mil (TTM As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Tianyu Pharmaceutical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Zhejiang Tianyu Pharmaceutical Co's Research & Development for the three months ended in Mar. 2025 was ¥53 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ¥242 Mil.


Zhejiang Tianyu Pharmaceutical Co Research & Development Historical Data

The historical data trend for Zhejiang Tianyu Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Tianyu Pharmaceutical Co Research & Development Chart

Zhejiang Tianyu Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 179.07 227.40 231.10 243.82 238.90

Zhejiang Tianyu Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.06 67.67 62.67 58.50 53.45

Zhejiang Tianyu Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥242 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Tianyu Pharmaceutical Co  (SZSE:300702) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Zhejiang Tianyu Pharmaceutical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Zhejiang Tianyu Pharmaceutical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Tianyu Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Chemical Development Zone, Zhejiang Province, Huangyan, Jiangkou, Taizhou, CHN, 318020
Zhejiang Tianyu Pharmaceutical Co Ltd is the pharmaceutical manufacturing company. Its main business is the development, production and sales of active pharmaceutical ingredients and intermediates. The products mainly include antihypertensive drug and intermediates, anti-asthma drug raw materials and intermediates, antiviral drug intermediates. Its products are well sold in domestic and overseas markets.
Executives
Cheng Rong De Directors, executives
Wang Yan Directors, executives
Lin Jie Director
Li Gong Yong Executives
Yang Xiao Song Executives
Fang Hong Jun Directors, executives
Zhu Guo Rong Executives
Zhang Yi Executives
Zhang Jia Liu Executives
Li Mei Jun Executives
Jiang Lu Lu Securities Affairs Representative
Tu Yong Jun Directors, executives

Zhejiang Tianyu Pharmaceutical Co Headlines

No Headlines